The company is committed to drug synthesis in fields of nutrition, narcotic analgesic, anticancer, antidepression, anti-senile dementia and cardiovascular, especially in the aspect of "narcotic analgesic and nutrition", as to which, the company is in the domestic leading position. Products of the company are mainly exported to more than 40 countries and areas in Southeast Asia, South America and Eastern Europe.
The company has completed quality assurance system and strong research and innovation ability. Every year, we bring out new synthetic drugs which are market demand-oriented with high technological content. We would like to provide you with efficient services by high quality products and competitive price.
During the 10th Five-Year Plan, We will continue to regard technological innovation as the main work, raise fund through various forms of introducing strategic investor, being listed, joint venture, capital increase and so on, increase research and development investment in new products, increase technological content of new products, and make greater contribution to development of China's medicine chemical industry.